Ossifying fibromyxoid tumor |
Multilobulated; nests/cords of uniform round-spindle cells; indistinct cytoplasm; no atypia (rarely high nuclear grade in malignant lesions); fibromyxoid stroma; partial rim of mature bone; and atypical osteoid in malignant tumors |
S100, desmin, GFAP (focal), and pankeratin (rare) |
PHF1 rearrangements (diverse fusion partners) |
Carcinoma (lobular, signet ring cell) |
Files-small nests; round-oval cells with variable cytoplasm and nuclear atypia; and intracytoplasmic mucin vacuole |
Pankeratins, lineage specific markers (depending on site of origine) |
Diverse (depending on site of origin) |
Sclerosing lymphoma |
Variably sized hyperchromatic-blastoid cells with variable atypia; scant cytoplasm; and sclerotic stroma |
CD45, B/T-cell markers |
Diverse |
Synovial sarcoma |
Sheets-fascicles; cellular, monomorphic spindle cells; high N/C ratio, variable epithelial differentiation; staghorn vessels; variable amount of collagen; mast cells; and calcification/ossification; poorly differentiated areas may show round-epithelioid cells |
CD99, BCL2, CD56, TLE1, S100 (focal), EMA, and keratins (variable) |
SS18-SSX1/2/4
|
Clear-cell sarcoma |
Nested-fascicular pattern; epithelioid-plump spindle cells with vesicular nuclei and macronucleoli; fibrous septa; and scattered wreath-like multinucleated giant cells |
Melanocytic markers (S100, SOX10, Melan-A, HMB45, and MITF) |
EWSR1-ATF1/CREB (most often); EWSR1-CREM (rare) |
Osteosarcoma |
Highly diverse; infiltrative growth; severely anaplastic and pleiomorphic cells; monomorphic small cell appearance is rare; and atypical neoplastic bone formation (essential) |
SATB2, osteocalcin (BGLAP), osteonectin (SPARC), osteoprotegerin (TNFRSF11B), RUNX2, S100, actins, CD99, keratin, and EMA |
Highly complex chromosomal aneuploidy |
Myoepithelioma |
Divers spectrum; reticular/trabecular pattern; variable spindle/epithelioid/clear/plasmocytoid/rhabdoid cells; rarely ductal component (mixed tumors); fibromyxoid stroma; and hyalinization |
Pankeratins, S100, EMA, GFAP, SOX10, P63, SMA, calponin, and desmin (focal) |
EWSR1 rearrangements (various fusion partners); PLAG1 rearrangements (mixed tumors) |